Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Non-invasive diagnosis and biomarkers in alcohol-related liver disease.

Moreno C, Mueller S, Szabo G.

J Hepatol. 2019 Feb;70(2):273-283. doi: 10.1016/j.jhep.2018.11.025. Review.

PMID:
30658728
2.
3.

Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease.

Lombardi R, Buzzetti E, Roccarina D, Tsochatzis EA.

World J Gastroenterol. 2015 Oct 21;21(39):11044-52. doi: 10.3748/wjg.v21.i39.11044. Review.

4.

Transient elastography alone and in combination with FibroTest® for the diagnosis of hepatic fibrosis in alcoholic liver disease.

Voican CS, Louvet A, Trabut JB, Njiké-Nakseu M, Dharancy S, Sanchez A, Corouge M, Lamouri K, Lebrun A, Balian A, Prévot S, Lachgar M, Maitre S, Agostini H, Mathurin P, Perlemuter G, Naveau S.

Liver Int. 2017 Nov;37(11):1697-1705. doi: 10.1111/liv.13440. Epub 2017 Sep 29.

PMID:
28387018
5.

Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease.

Fernandez M, Trépo E, Degré D, Gustot T, Verset L, Demetter P, Devière J, Adler M, Moreno C.

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1074-9. doi: 10.1097/MEG.0000000000000392.

PMID:
26011235
6.

Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.

Piscaglia F, Salvatore V, Mulazzani L, Cantisani V, Schiavone C.

Ultraschall Med. 2016 Feb;37(1):1-5. doi: 10.1055/s-0035-1567037. Epub 2016 Feb 12.

PMID:
26871407
7.

Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.

Pavlov CS, Casazza G, Nikolova D, Tsochatzis E, Burroughs AK, Ivashkin VT, Gluud C.

Cochrane Database Syst Rev. 2015 Jan 22;1:CD010542. doi: 10.1002/14651858.CD010542.pub2. Review.

8.

Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.

Thiele M, Madsen BS, Hansen JF, Detlefsen S, Antonsen S, Krag A.

Gastroenterology. 2018 Apr;154(5):1369-1379. doi: 10.1053/j.gastro.2018.01.005. Epub 2018 Jan 6.

PMID:
29317276
9.

Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.

Park CC, Nguyen P, Hernandez C, Bettencourt R, Ramirez K, Fortney L, Hooker J, Sy E, Savides MT, Alquiraish MH, Valasek MA, Rizo E, Richards L, Brenner D, Sirlin CB, Loomba R.

Gastroenterology. 2017 Feb;152(3):598-607.e2. doi: 10.1053/j.gastro.2016.10.026. Epub 2016 Oct 27.

10.

Update of liver fibrosis and steatosis with transient elastography (Fibroscan).

Wong GL.

Gastroenterol Rep (Oxf). 2013 Jul;1(1):19-26. doi: 10.1093/gastro/got007. Epub 2013 Mar 26.

11.

Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.

Stibbe KJ, Verveer C, Francke J, Hansen BE, Zondervan PE, Kuipers EJ, de Knegt RJ, van Vuuren AJ.

Scand J Gastroenterol. 2011 Jul;46(7-8):962-72. doi: 10.3109/00365521.2011.574725. Epub 2011 May 30.

PMID:
21623677
12.

Non-invasive diagnosis of alcoholic liver disease.

Mueller S, Seitz HK, Rausch V.

World J Gastroenterol. 2014 Oct 28;20(40):14626-41. doi: 10.3748/wjg.v20.i40.14626. Review.

13.

Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.

Crossan C, Tsochatzis EA, Longworth L, Gurusamy K, Davidson B, Rodríguez-Perálvarez M, Mantzoukis K, O'Brien J, Thalassinos E, Papastergiou V, Burroughs A.

Health Technol Assess. 2015 Jan;19(9):1-409, v-vi. doi: 10.3310/hta19090. Review.

14.

Non-invasive diagnosis of hepatitis B virus-related cirrhosis.

Lee S, Kim DY.

World J Gastroenterol. 2014 Jan 14;20(2):445-59. doi: 10.3748/wjg.v20.i2.445. Review.

15.

The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption.

Imbert-Bismut F, Naveau S, Morra R, Munteanu M, Ratziu V, Abella A, Messous D, Thabut D, Benhamou Y, Poynard T.

Eur J Gastroenterol Hepatol. 2009 Jan;21(1):18-27. doi: 10.1097/MEG.0b013e32830a4f4c.

PMID:
19011575
16.

Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.

Arora A, Sharma P.

J Clin Exp Hepatol. 2012 Jun;2(2):145-55. doi: 10.1016/S0973-6883(12)60103-0. Epub 2012 Jul 21.

17.

Optimization of hepatitis B cirrhosis detection by stepwise application of transient elastography and routine biomarkers.

Liang XE, Zhong C, Huang L, Yang S, Zhu Y, Chen Y, Hou J.

J Gastroenterol Hepatol. 2017 Feb;32(2):459-465. doi: 10.1111/jgh.13475.

PMID:
27346683
18.

Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C.

Ragazzo TG, Paranagua-Vezozzo D, Lima FR, de Campos Mazo DF, Pessoa MG, Oliveira CP, Alves VAF, Carrilho FJ.

Clinics (Sao Paulo). 2017 Oct;72(9):516-525. doi: 10.6061/clinics/2017(09)01.

19.

Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis.

Hartl J, Denzer U, Ehlken H, Zenouzi R, Peiseler M, Sebode M, Hübener S, Pannicke N, Weiler-Normann C, Quaas A, Lohse AW, Schramm C.

J Hepatol. 2016 Oct;65(4):769-775. doi: 10.1016/j.jhep.2016.05.023. Epub 2016 May 26.

PMID:
27238753
20.

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.

Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y, Ono M, Eguchi Y, Inoue T, Yamanaka T, Wada K, Saito S, Nakajima A.

Gastroenterology. 2016 Mar;150(3):626-637.e7. doi: 10.1053/j.gastro.2015.11.048. Epub 2015 Dec 8.

Supplemental Content

Support Center